What's in Charlotte-Paige Rolle, MD's pipeline?

Charlotte-Paige Rolle, MD has 2 drugs in our index: 2 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Charlotte-Paige Rolle, MD's portfolio?

Top competitors by shared drug class: CAN Community Health, Denver Infectious Disease Consultants, PLLC, Fundacion SEIMC-GESIDA, Fundação Bahiana de Infectologia, Hospitales Universitarios Virgen del Rocío.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/charlotte-paige-rolle-md.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Charlotte-Paige Rolle, MD — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Charlotte-Paige Rolle, MD pipeline: 2 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 0 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Dolutegravir / Lamivudine Pill	Dolutegravir / Lamivudine Pill	marketed	Antiretroviral combination (INSTI + NRTI)	HIV integrase; HIV reverse transcriptase	Infectious Disease / Virology
Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill	Bictegravir / Emtricitabine / Tenofovir Alafenamide Pill	marketed	Antiretroviral combination (integrase inhibitor + nucleoside reverse transcriptase inhibitors)	HIV integrase, HIV reverse transcriptase	Infectious Disease / Virology

Therapeutic area mix

Infectious Disease / Virology · 2

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

CAN Community Health · 1 shared drug class
Denver Infectious Disease Consultants, PLLC · 1 shared drug class
Fundacion SEIMC-GESIDA · 1 shared drug class
Fundação Bahiana de Infectologia · 1 shared drug class
Hospitales Universitarios Virgen del Rocío · 1 shared drug class
Midland Research Group, Inc. · 1 shared drug class
Saint Michael's Medical Center · 1 shared drug class
The University of Texas Health Science Center, Houston · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Charlotte-Paige Rolle, MD:

Cite this brief

Drug Landscape (2026). Charlotte-Paige Rolle, MD — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/charlotte-paige-rolle-md. Accessed 2026-05-17.